Melissa Snyder, Ph.D.

As Executive Director of Program Strategy, Dr. Melissa Snyder is responsible for strategic planning, coordination, knowledge, and subject matter expertise for projects and consultative services. She contributes to designing effective and efficient clinical trials/programs bringing specific regulatory, medical/scientific and operational knowledge in the Neuroscience Therapeutic area. Previously, Dr. Snyder worked as Director of Clinical Research for a small biotechnology company. There, working closely with the chief medical officer, clinical operations and regulatory team, Dr. Snyder supported Phase I-III clinical studies including clinical trial design, protocol writing, statistical analysis plan development, and trial oversight. In her previous position at a clinical research site, she established visibility within the community and formed strategic partnerships increasing the patient database and clinical trial offerings.

Dr. Snyder spent years in basic science research exploring the pathophysiological mechanisms of epilepsy, schizophrenia, and Alzheimer’s disease. Her therapeutic areas of expertise for clinical trials include Alzheimer’s Disease, Major Depressive Disorder, and Tuberous Sclerosis Complex. Her clinical trial work spanned the United States, Canada, Australia, and the Republic of Korea.

Dr. Snyder obtained her Ph.D. in Neuroscience from Northwestern University in Evanston, IL and a BSc in Neuroscience from Allegheny College in Meadville, PA.